Stephen Keen
11Patents
6h-index
23Co-inventors
62Inventor score
Filing activity: Mar 4, 2004 → Sep 17, 2021
Most-cited inventions
| Patent | Title | Area | Cited by | Status |
|---|---|---|---|---|
| US9809536B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 11 | Active |
| US9822121B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 11 | Active |
| US10087189B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 10 | Active |
| US10435410B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 9 | Active |
| US10577316B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 7 | Active |
| US10899771B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 7 | Active |
| US11124478B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 5 | Active |
| US11708371B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 3 | Active |
| US11767292B2 | Process for making beta 3 agonists and intermediates | Chemistry; Metallurgy | 3 | Active |
| US7288655B2 | α v integrin receptor antagonists | Chemistry; Metallurgy | 0 | Expired |
| US7759492B2 | Enantioselective synthesis of 13-oxotricyclo[8.2.1.0.3,8] trideca-3(8),4,6-triene-5-carboxylates | Chemistry; Metallurgy | 0 | Active |
Source: USPTO / EPO open patent data. Inventor disambiguation is heuristic; counts are objective bibliographic measures.